Patent holdings for IPC class A61K 31/4184

Total number of patents in this class: 4977

10-year publication summary

347
378
337
367
410
333
314
356
316
125
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Boehringer Ingelheim International GmbH
4494
67
The Regents of the University of California
20594
54
Immunomedics, Inc.
243
44
Takeda Pharmaceutical Company Limited
2717
42
The Johns Hopkins University
5837
41
Janssen Pharmaceutica N.V.
3217
39
Merck Sharp & Dohme LLC
3736
38
Novartis AG
10340
36
Abbvie Inc.
1839
34
Gilead Sciences, Inc.
2200
34
AstraZeneca AB
2823
33
HK Inno.n Corporation
118
32
Bristol-myers Squibb Company
4797
31
Eagle Pharmaceuticals, Inc.
106
31
Boehringer Ingelheim Vetmedica GmbH
1272
30
Array BioPharma Inc.
457
30
Dana-Farber Cancer Institute, Inc.
2648
30
Purdue Pharmaceutical Products L.P.
32
29
Achillion Pharmaceuticals, Inc.
159
28
Purdue Pharma L.P.
492
28
Other owners 4246